Australia markets close in 4 hours 25 minutes

Gamida Cell Ltd. (GMDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4300-0.1200 (-7.74%)
At close: 04:00PM EST
1.4600 +0.03 (+2.10%)
After hours: 06:07PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.5500
Open1.5300
Bid1.4300 x 3200
Ask1.4800 x 1100
Day's range1.4000 - 1.5300
52-week range1.3200 - 4.7200
Volume504,024
Avg. volume510,682
Market cap106.365M
Beta (5Y monthly)1.62
PE ratio (TTM)N/A
EPS (TTM)-1.5310
Earnings date14 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est12.40
  • Business Wire

    Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences

    BOSTON, November 23, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced that members of the management team will present at the following upcoming investor conferences:

  • Business Wire

    Gamida Cell Provides Regulatory Update on Omidubicel

    BOSTON, November 21, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematological and solid cancers and other serious diseases, today provided an update on recent interactions with the U.S. Food and Drug Administration (FDA) relating to the company’s Biologics License Application (BLA) for omidubicel, the company’s advanced cell therapy candidate for allogeneic hematopoietic stem cell transplant.

  • Business Wire

    Gamida Cell Reports Third Quarter 2022 Financial Results and Provides Company Update

    BOSTON, November 14, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today provided a business update and reported financial results for the quarter ended September 30, 2022. Net loss for the third quarter of 2022 was $17.8 million, compared to a net loss of $23.2 million in the third quarter of 2021. As of September 30, 2022, Gamida Cell had total cash, cash equivalents